Lock Kenneth A. 5
5 · Arcutis Biotherapeutics, Inc. · Filed Feb 16, 2021
Insider Transaction Report
Form 5
Lock Kenneth A.
Chief Commercial Officer
Transactions
- Award
Common Stock
2020-05-31$14.45/sh+1,004$14,508→ 23,100 total - Award
Common Stock
2020-11-30$23.05/sh+233$5,371→ 23,100 total
Footnotes (2)
- [F1]Shares acquired pursuant to the Issuer's Employee Stock Purchase Plan.
- [F2]Includes 9,000 Restricted Stock Units ("RSUs"). The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof.